Synthesis, mode of action, and biological activities of rebeccamycin bromo derivatives

被引:37
作者
Moreau, P
Anizon, F
Sancelme, M
Prudhomme, M [1 ]
Sevère, D
Riou, JF
Goossens, JF
Hénichart, JP
Bailly, C
Labourier, E
Tazzi, J
Fabbro, D
Meyer, T
Aubertin, AM
机构
[1] Univ Blaise Pascal, UMR 6504, F-63177 Aubiere, France
[2] Rhone Poulenc Rorer, F-93403 Vitry Sur Seine, France
[3] Fac Pharm, F-59006 Lille, France
[4] Ctr Oscar Lambret, F-59045 Lille, France
[5] INSERM, U124, F-59045 Lille, France
[6] Inst Genet Mol, UMR 5535, F-34093 Montpellier, France
[7] Novartis, Dept Oncol, CH-4002 Basel, Switzerland
[8] Univ Strasbourg 1, INSERM, U74, Strasbourg, France
关键词
D O I
10.1021/jm980702n
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Bromo analogues of the natural metabolite rebeccamycin with and without a methyl substituent on the imide nitrogen were synthesized. The effects of the drugs on protein kinase C, the binding to DNA, and the effect on topoisomerase I were determined. The drugs' uptake and their antiproliferative activities against P388 leukemia cells sensitive and resistant to camptothecin, their antimicrobial activity against a Gram-positive bacterium (B. cereus), and their anti-HIV-1 activity were measured and compared to those of the chlorinated and dechlorinated analogues. Dibrominated imide 5 shows a remarkable activity against topoisomerase I, affecting both the kinase and DNA cleavage activity of the enzyme. The marked cytotoxic potency of this compound depends essentially on its capacity to inhibit topoisomerase I.
引用
收藏
页码:1816 / 1822
页数:7
相关论文
共 30 条
[1]   Syntheses and biological activities (topoisomerase inhibition and antitumor and antimicrobial properties) of rebeccamycin analogues bearing modified sugar moieties and substituted on the imide nitrogen with a methyl group [J].
Anizon, F ;
Belin, L ;
Moreau, P ;
Sancelme, M ;
Voldoire, A ;
Prudhomme, M ;
Ollier, M ;
Severe, D ;
Riou, JF ;
Bailly, C ;
Fabbro, D ;
Meyer, T .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (21) :3456-3465
[2]   DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin [J].
Bailly, C ;
Riou, JF ;
Colson, P ;
Houssier, C ;
RodriguesPereira, E ;
Prudhomme, M .
BIOCHEMISTRY, 1997, 36 (13) :3917-3929
[3]   SEQUENCE-SPECIFIC CLEAVAGE OF DNA BY N-BROMOACETYLDISTAMYCIN - PRODUCT AND KINETIC ANALYSES [J].
BAKER, BF ;
DERVAN, PB .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1989, 111 (07) :2700-2712
[4]   SYNTHESIS OF ARCYRIARUBIN B AND RELATED BISINDOLYLMALEIMIDES [J].
BRENNER, M ;
REXHAUSEN, H ;
STEFFAN, B ;
STEGLICH, W .
TETRAHEDRON, 1988, 44 (10) :2887-2892
[5]   PRODUCTION AND BIOLOGICAL-ACTIVITY OF REBECCAMYCIN, A NOVEL ANTITUMOR AGENT [J].
BUSH, JA ;
LONG, BH ;
CATINO, JJ ;
BRADNER, WT .
JOURNAL OF ANTIBIOTICS, 1987, 40 (05) :668-678
[6]  
Cleary J., 1996, Proceedings of the American Association for Cancer Research Annual Meeting, V37, P164
[7]  
DARPA P, 1989, BIOCHIM BIOPHYS ACTA, V989, P1
[8]   TOPOISOMERASE POISONS - HARNESSING THE DARK SIDE OF ENZYME MECHANISM [J].
FROELICHAMMON, SJ ;
OSHEROFF, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (37) :21429-21432
[9]  
GOOSSENS JF, UNPUB CELLULAR UPTAK
[10]   ON THE MECHANISM OF TOPOISOMERASE-I INHIBITION BY CAMPTOTHECIN - EVIDENCE FOR BINDING TO AN ENZYME DNA COMPLEX [J].
HERTZBERG, RP ;
CARANFA, MJ ;
HECHT, SM .
BIOCHEMISTRY, 1989, 28 (11) :4629-4638